COMMUNIQUÉS West-GlobeNewswire

NutrifyGenie by Nutrify Today Establishes New AI Standards in Dietary Supplement Development

15/08/2024 - 15:03

BANGALORE, India, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Nutrify Today ’s NutrifyGenie AI has hit a major milestone as the first AI technology in the natural products industry to successfully produce 12 commercialized [...]

Lumos Pharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference

15/08/2024 - 15:00

AUSTIN, Texas, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced that the Company will participate in the [...]

Aligos Therapeutics Announces Reverse Stock Split

15/08/2024 - 15:00

SOUTH SAN FRANCISCO, Calif., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to [...]

Glucotrack’s Innovative Blood Glucose Monitoring Concept Resonates with Patients with Diabetes, According to New Survey Presented at Association of Diabetes Care and Education Specialists (ADCES) 2024 Annual Conference

15/08/2024 - 15:00

Glucotrack ADCES poster highlights over 50% of surveyed diabetes patients are open to new Continuous Blood Glucose Monitor concept Rutherford, NJ, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“ [...]

Tevogen Bio Reports Second Quarter 2024 Financial Results, Eliminates Doubt About Company’s Ability to Continue as a Going Concern, Eliminates Series B Preferred Shares

15/08/2024 - 15:00

WARREN, N.J., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically [...]

International Myeloma Foundation Medical Student Scholars for Health Equity in Myeloma Present Posters at the 2024 NMA Annual Convention & Scientific Assembly

15/08/2024 - 14:45

NEW YORK, Aug. 15, 2024 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF), in partnership with the National Medical Association (NMA), the W. Montague Cobb Institute, and the Student National Medical [...]

Sienna Announces August Dividend

15/08/2024 - 14:30

MARKHAM, Ontario, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “ Common Share ”) [...]

BioCorRx Reports Business Update for the Second Quarter of 2024

15/08/2024 - 14:30

ANAHEIM, CA, Aug. 15, 2024 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of innovative treatment programs for substance abuse and related disorders, today provided a business [...]

Orion Corporation: Managers’ transactions – Hao Pan

15/08/2024 - 14:30

ORION CORPORATION MANAGERS’ TRANSACTIONS 15 AUGUST 2024 at 15.30 EEST Orion Corporation: Managers’ transactions – Hao Pan Orion Corporation has received the following disclosure under Market Abuse Regulation (EU) No 596 [...]

LIXTE Biotechnology Holdings to Present at Two Investor Conferences

15/08/2024 - 14:30

-Company to Present August 20 at Investor Summit Summer 2024 Virtual Conference; and September 9-11 at H.C. Wainwright 26 th Annual Global Investment Conference- PASADENA, CALIF., Aug. 15, 2024 (GLOBE NEWSWIRE) -- LIXTE [...]

Pathos Expands Pipeline With Worldwide License of Phase 2-ready Brain-penetrant, PRMT5 Inhibitor

15/08/2024 - 14:00

CHICAGO, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Pathos AI, Inc. ( www.pathos.com ), a biotechnology company focused on revolutionizing precision medicine in cancer by harnessing the power of machine learning to transform [...]

DiagnaMed Offering its Brain Health AI Platform for Investigating Weight Loss Drugs, such as Semaglutide (GLP-1), on Brain Function

15/08/2024 - 14:00

TORONTO, Aug. 15, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, is offering its novel [...]

Tempest Announces Successful End-of-Phase 2 Meeting with FDA for Amezalpat (TPST-1120) to Treat First-Line Hepatocellular Carcinoma

15/08/2024 - 14:00

Broad agreement on pivotal Phase 3 study plan, including use of current amezalpat dose and schedule Overall survival, the strongest result from the Phase 2 trial, will be the primary study endpoint Agreed-upon early [...]

Empower: Discover the Future of Healthcare at Inovalon’s Annual Data-Driven Summit

15/08/2024 - 14:00

Hear from Former CDC Director and Visionary Executives from AWS, Oracle Cloud Infrastructure, Snowflake, and Many Other Organizations on the Forefront of Data-Driven Healthcare BOWIE, Md., Aug. 15, 2024 (GLOBE NEWSWIRE [...]

Noah Medical Shares Diagnostic Confidence of its Galaxy Users at AABIP 2024

15/08/2024 - 14:00

Next-generation robotics company to share field results, deliver interactive simulations and host multiple events for its Galaxy System at leading bronchology and pulmonology gathering SAN CARLOS, Calif., Aug. 15, 2024 [...]

Oculis Appoints Sharon Klier, M.D., M.S., M.P.H. as Chief Development Officer

15/08/2024 - 14:00

Dr. Klier brings significant experience in ophthalmology and drug development with a proven track record in U.S. FDA approvals, which will be instrumental as the company advances its late-stage pipeline Appointment [...]

Lifeward Reports Second Quarter 2024 Financial Results

15/08/2024 - 14:00

Record ReWalk revenue with 20 systems placed Q2’24 revenue of $6.7M up over 400% compared to $1.3M in Q2’23 Medicare claims for submissions from prior quarters beginning to be paid MARLBOROUGH, Mass. and YOKNEAM ILLIT, [...]

Oculis Appoints Sharon Klier, M.D., M.S., M.P.H. as Chief Development Officer

15/08/2024 - 14:00

ZUG, Switzerland, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced the appointment [...]

Genetic Technologies Announces Global Launch of geneType™ on Wholly Owned EasyDNA platform

15/08/2024 - 14:00

CHARLOTTE, N.C., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in genomics-based tests in health, wellness and serious disease and the parent [...]